We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Declines More Than Market: Some Information for Investors
Read MoreHide Full Article
In the latest trading session, Albemarle (ALB - Free Report) closed at $90.53, marking a -1.63% move from the previous day. This change lagged the S&P 500's daily loss of 0.38%. Elsewhere, the Dow lost 0.2%, while the tech-heavy Nasdaq lost 0.67%.
The stock of specialty chemicals company has risen by 12.23% in the past month, leading the Basic Materials sector's gain of 0.97% and the S&P 500's gain of 4.06%.
Market participants will be closely following the financial results of Albemarle in its upcoming release. The company plans to announce its earnings on November 5, 2025. The company's earnings per share (EPS) are projected to be -$0.97, reflecting a 37.42% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $1.27 billion, indicating a 5.92% decrease compared to the same quarter of the previous year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$1.85 per share and a revenue of $4.98 billion, indicating changes of +20.94% and -7.48%, respectively, from the former year.
Investors should also note any recent changes to analyst estimates for Albemarle. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. As of now, Albemarle holds a Zacks Rank of #2 (Buy).
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 233, which puts it in the bottom 6% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Albemarle (ALB) Declines More Than Market: Some Information for Investors
In the latest trading session, Albemarle (ALB - Free Report) closed at $90.53, marking a -1.63% move from the previous day. This change lagged the S&P 500's daily loss of 0.38%. Elsewhere, the Dow lost 0.2%, while the tech-heavy Nasdaq lost 0.67%.
The stock of specialty chemicals company has risen by 12.23% in the past month, leading the Basic Materials sector's gain of 0.97% and the S&P 500's gain of 4.06%.
Market participants will be closely following the financial results of Albemarle in its upcoming release. The company plans to announce its earnings on November 5, 2025. The company's earnings per share (EPS) are projected to be -$0.97, reflecting a 37.42% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $1.27 billion, indicating a 5.92% decrease compared to the same quarter of the previous year.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$1.85 per share and a revenue of $4.98 billion, indicating changes of +20.94% and -7.48%, respectively, from the former year.
Investors should also note any recent changes to analyst estimates for Albemarle. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. As of now, Albemarle holds a Zacks Rank of #2 (Buy).
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 233, which puts it in the bottom 6% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.